Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference
May 01 2006 - 5:15PM
PR Newswire (US)
SAN DIEGO, May 1 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals,
Inc. (NASDAQ:AMLN) will be presenting at the Morgan Stanley Global
Healthcare Unplugged Conference on Friday, May 5, 2006 at 9:30 a.m.
ET in Miami, FL. Daniel Bradbury, Chief Operating Officer of Amylin
Pharmaceuticals, will be providing a corporate overview. The live
presentation will be webcast, and a recording will be made
available following the event. The webcast and recording will be
accessible through Amylin's corporate website, located at
http://www.amylin.com/. To access the live webcast, please log on
to Amylin's site approximately fifteen minutes prior to the
presentation to register and download any necessary audio software.
Amylin Pharmaceuticals is committed to improving the lives of
people with diabetes and other metabolic diseases through the
discovery, development and commercialization of innovative,
cost-effective medicines. DATASOURCE: Amylin Pharmaceuticals, Inc.
CONTACT: Alice Bahner, Executive Director, Investor Relations of
Amylin Pharmaceuticals, Inc., +1-858-552-2200, Ext. 7272 Web site:
http://www.amylin.com/
Copyright
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jul 2023 to Jul 2024